413 related articles for article (PubMed ID: 11516832)
1. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
Campbell BM; Gresch PJ; Walker PD
Neuroscience; 2001; 105(3):671-80. PubMed ID: 11516832
[TBL] [Abstract][Full Text] [Related]
2. Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat.
Gresch PJ; Walker PD
Brain Res Mol Brain Res; 1999 Jun; 70(1):125-34. PubMed ID: 10381550
[TBL] [Abstract][Full Text] [Related]
3. Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion.
Basura GJ; Walker PD
Brain Res Mol Brain Res; 2001 Aug; 92(1-2):66-77. PubMed ID: 11483243
[TBL] [Abstract][Full Text] [Related]
4. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
Van De Witte SV; Groenewegen HJ; Voorn P
Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
[TBL] [Abstract][Full Text] [Related]
5. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
Campbell BM; Kreipke CW; Walker PD
Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
[TBL] [Abstract][Full Text] [Related]
6. MK-801 prevents dopamine D1 but not serotonin 2A stimulation of striatal preprotachykinin mRNA expression.
Campbell BM; Walker PD
Neuroreport; 2001 Apr; 12(5):953-5. PubMed ID: 11303767
[TBL] [Abstract][Full Text] [Related]
7. Regulation of striatal neuropeptide mRNAs: effects of the 5-HT(2) antagonist SR46349B in adult rats with a neonatal 6-hydroxydopamine lesion.
Durand C; Mathieu-Kia AM; Besson MJ; Penit-Soria J
J Neurosci Res; 2002 Jan; 67(1):86-92. PubMed ID: 11754083
[TBL] [Abstract][Full Text] [Related]
8. Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease.
Gresch PJ; Walker PD
Neuroscience; 1999; 93(3):831-41. PubMed ID: 10473249
[TBL] [Abstract][Full Text] [Related]
9. NMDA receptor antagonism modifies the synergistic regulation of striatal tachykinin gene expression induced by dopamine D(1) and serotonin(2) receptor stimulation following neonatal dopamine depletion.
Campbell BM; Walker PD
Brain Res Mol Brain Res; 2001 Sep; 93(1):90-4. PubMed ID: 11532342
[TBL] [Abstract][Full Text] [Related]
10. Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats.
Bishop C; Walker PD
Neuroscience; 2003; 121(3):649-57. PubMed ID: 14568025
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.
Morissette M; Grondin R; Goulet M; Bédard PJ; Di Paolo T
J Neurochem; 1999 Feb; 72(2):682-92. PubMed ID: 9930741
[TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor agonists regulate levels of the serotonin 5-HT2A receptor and its mRNA in a subpopulation of rat striatal neurons.
Laprade N; Radja F; Reader TA; Soghomonian JJ
J Neurosci; 1996 Jun; 16(11):3727-36. PubMed ID: 8642415
[TBL] [Abstract][Full Text] [Related]
13. Stimulated serotonin release from hyperinnervated terminals subsequent to neonatal dopamine depletion regulates striatal tachykinin, but not enkephalin gene expression.
Basura GJ; Walker PD
Brain Res Mol Brain Res; 2000 Sep; 81(1-2):80-91. PubMed ID: 11000480
[TBL] [Abstract][Full Text] [Related]
14. Locomotor-activity-induced changes in striatal levels of preprotachykinin and preproenkephalin mRNA. Regulation by the dopaminergic and glutamatergic systems.
Liste I; Rodriguez-Pallares J; Caruncho HJ; Labandeira-Garcia JL
Brain Res Mol Brain Res; 1999 Jun; 70(1):74-83. PubMed ID: 10381545
[TBL] [Abstract][Full Text] [Related]
15. Effect of repeated administration of dopamine agonists on striatal neuropeptide mRNA expression in rats with a unilateral nigral 6-hydroxydopamine lesion.
Granata R; Wenning GK; Jolkkonen J; Jenner P; Marsden CD
J Neural Transm (Vienna); 1996; 103(3):249-60. PubMed ID: 8739837
[TBL] [Abstract][Full Text] [Related]
16. Striatal preprotachykinin mRNA levels are regulated by stimulatory agents and dopamine D1 receptor manipulation in rodent organotypic slice cultures.
Campbell BM; Walker PD
Brain Res; 2001 Jan; 888(1):26-33. PubMed ID: 11146049
[TBL] [Abstract][Full Text] [Related]
17. Striatal tachykinin and enkephalin mRNAs are normalized by serotonin2 and NMDA manipulation following dopamine depletion.
Campbell BM; Walker PD
Neuroreport; 2002 Jan; 13(1):5-8. PubMed ID: 11924893
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels.
Cenci MA; Campbell K; Björklund A
Neuroscience; 1993 Nov; 57(2):275-96. PubMed ID: 8115038
[TBL] [Abstract][Full Text] [Related]
19. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
Harrison MB; Kumar S; Hubbard CA; Trugman JM
Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620
[TBL] [Abstract][Full Text] [Related]
20. Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6-hydroxydopamine-lesioned rat striatum parallels functional recovery.
Zeng BY; Jenner P; Marsden CD
Mov Disord; 1996 Jan; 11(1):43-52. PubMed ID: 8771066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
